How much does a box of Trientine cost?

Trientine(Trientine) is a rare disease drug mainly used to treat copper metabolism disorders such as Wilson's disease. Due to the small number of patients and high production costs, its market price has remained high. Currently, the original drug trientine is produced by British Univar Solutions in cooperation with Japanese pharmaceutical companies, and has been marketed in many European countries. In the Chinese market, although trientine has been imported through specific channels, it has not yet been included in the national medical insurance catalog. Patients usually need to obtain it through hospital import pharmacies or cross-border drug purchase channels, so the price fluctuates greatly.

According to overseas drug price data, the German version of trientine original drugThe price of 200mg*100 tablets may be more than RMB 40,000. The specific amount will vary due to exchange rate changes, import channels and transportation costs. The reason for its high price is not only the cost of R&D and certification of rare disease drugs, but also related to drug storage and transportation conditions and low market demand. In contrast, some pharmaceutical factories in India have developed generic versions whose active ingredients are the same as the original drugs. The pharmacological effects of chelated copper ions are basically the same, and their clinical efficacy is also recognized. However, the price of generic drugs is usually lower than that of original drugs, and because they have not been officially registered and marketed in China, there is still a lack of open and transparent standards for specific selling prices.

It is worth noting that trientine treatment often requires long-term or even lifelong use. Therefore, patients should comprehensively consider drug quality, stability and doctor's guidance when choosing a drug source. Although overseas generic drugs are more affordable, it is necessary to ensure formal drug purchase channels to avoid purchasing uncertified informal products. In the future, as China strengthens policy support for rare diseases and optimizes the review channels for imported drugs, trientine is expected to gradually reduce costs and expand clinical accessibility.

Reference materials:https://www.cufence.com/